{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:57:00Z","timestamp":1781459820969,"version":"3.54.1"},"reference-count":28,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TR004529-01"],"award-info":[{"award-number":["TR004529-01"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K24AG054415"],"award-info":[{"award-number":["K24AG054415"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Hosp Palliat Care"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serious illness communication occurs with &lt;10% of outpatients with end-stage liver disease (ESLD), despite high morbidity and mortality. We determined the feasibility of assessing changes in readiness for serious illness communication engagement following an evidence-based intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single group pre-post evaluation of a pilot intervention in adults with ESLD in an outpatient hepatology clinic. Study intervention included a standard outpatient hepatology visit with addition of a serious illness conversation performed by one hepatologist trained in evidence-based communication frameworks. Serious illness communication engagement was measured using a validated survey at baseline and over 6 months. Sociodemographic, clinical information, and post-study qualitative data were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      31 participants enrolled and 22 participants (70.9%) completed the 6-month assessment. The mean age was 53 years, 42% (n = 13) were female, 55% (n = 17) self-identified as non-White and\/or Hispanic ethnicity, 60% (n = 18) had more than a high school education, and 65% (n = 20) were not partnered. SIC readiness improved immediately following the SIC intervention (mean 4.0, SD 1.0,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and was maintained at 3 months (mean 4.0, SD 1.1,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and 6 months (mean 3.8, SD 1.3,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002). Post-study qualitative data showed participants were comfortable with serious illness communication, desired provider initiation and family involvement with a preference for outpatient conversations with a known provider.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our hepatologist-led, evidence-based intervention resulted in clinically meaningful and statistically significant increases in serious illness communication readiness for patients with ESLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10499091261454918","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:02:58Z","timestamp":1781258578000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence-Based Frameworks Increase Engagement in Serious Illness Communication Conversations for Patients With Cirrhosis"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-8631","authenticated-orcid":false,"given":"Cristal","family":"Brown","sequence":"first","affiliation":[{"name":"University of Texas at Austin"},{"name":"Division of Gastroenterology, Ascension Medical Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyberius","family":"Ford","sequence":"additional","affiliation":[{"name":"University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabecca","family":"Hernandez","sequence":"additional","affiliation":[{"name":"University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4997-4386","authenticated-orcid":false,"given":"Nazan","family":"Aksan","sequence":"additional","affiliation":[{"name":"Dell Medical School at the University of Texas at Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brooke","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Ascension Medical Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pignone","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Muir","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Sudore","sequence":"additional","affiliation":[{"name":"University of California"},{"name":"Departement of Medicine, San Francisco Veterans Affairs Health Care System"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2019.12.355"},{"key":"e_1_3_6_3_2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.14309\/ajg.0000000000002570","article-title":"Outcomes of a 3-Year quality improvement study to improve advance care planning in patients with decompensated cirrhosis","volume":"119","author":"Patel A","year":"2023","unstructured":"Patel A, Bowman CA, Prause N, et al. Outcomes of a 3-Year quality improvement study to improve advance care planning in patients with decompensated cirrhosis. Am J Gastroenterol. 2023;119:580-583.","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2018.0261"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263874"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.03.022"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2015-100613"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2024.04.003"},{"key":"e_1_3_6_9_2","first-page":"885066624128089","article-title":"Barriers and strategies to effective serious illness communication for patients with end-stage liver disease in the intensive care setting","volume":"41","author":"Brown C","year":"2024","unstructured":"Brown C, Khan S, Parekh TM, Muir AJ, Sudore RL. Barriers and strategies to effective serious illness communication for patients with end-stage liver disease in the intensive care setting. J Intensive Care Med. 2024;41:8850666241280892.","journal-title":"J Intensive Care Med"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4040518"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.3.164"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.018796"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.12.005"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32378"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1849"},{"key":"e_1_3_6_16_2","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1001\/jamainternmed.2014.5271","article-title":"American college of physicians high value care task F. Communication about serious illness care goals: a review and synthesis of best practices","volume":"174","author":"Bernacki RE","year":"2014","unstructured":"Bernacki RE, Block SD, American College of Physicians High Value Care Task Force. American college of physicians high value care task F. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174:1994-2003.","journal-title":"JAMA Intern Med"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2023.04.015"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.10.367"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/082585971403000105"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10620-024-08667-4","article-title":"Safety and efficacy of dapagliflozin in recurrent ascites: a pilot study","volume":"70","author":"Singh V","year":"2025","unstructured":"Singh V, De A, Aggrawal R, Singh A, Charak S, Bhagat N. Safety and efficacy of dapagliflozin in recurrent ascites: a pilot study. Dig Dis Sci. 2025;70:835-842.","journal-title":"Dig Dis Sci"},{"key":"e_1_3_6_21_2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12072-022-10334-7","article-title":"Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia","volume":"16","author":"Mohta S","year":"2022","unstructured":"Mohta S, Anand A, Sharma S, et al. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia. Hepatol Int. 2022;16:680-690.","journal-title":"Hepatol Int"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.10.018"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530200027032"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-7-21"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.19445"},{"key":"e_1_3_6_26_2","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1136\/bmjspcare-2020-002830","article-title":"Serious illness conversations in advanced kidney disease: a mixed-methods implementation study","volume":"14","author":"Thamcharoen N","year":"2021","unstructured":"Thamcharoen N, Nissaisorakarn P, Cohen RA, et al. Serious illness conversations in advanced kidney disease: a mixed-methods implementation study. BMJ Support Palliat Care. 2021;14:e928-935.","journal-title":"BMJ Support Palliat Care"},{"key":"e_1_3_6_27_2","volume-title":"The Liver Meeting","author":"Verma M","year":"2024","unstructured":"Verma M, Reeve B, Jakab S, et al. Psychometric properties of a novel tool to measure goal concordant care (GCC) from patients with end stage liver disease, and their caregivers. The Liver Meeting. San Diego, California: American Association for the Study of Liver Diseases; 2024."},{"issue":"10","key":"e_1_3_6_28_2","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.cgh.2024.10.017","article-title":"Prognostic communication, symptom burden, psychological distress, and quality of life among patients with decompensated cirrhosis","volume":"23","author":"Donlan J","year":"2024","unstructured":"Donlan J, Kaplan A, Noll A, et al. Prognostic communication, symptom burden, psychological distress, and quality of life among patients with decompensated cirrhosis. Clin Gastroenterol Hepatol. 2024;23(10):1746-1754.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06369-1"}],"container-title":["American Journal of Hospice and Palliative Medicine\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10499091261454918","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10499091261454918","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10499091261454918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:09:02Z","timestamp":1781456942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10499091261454918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":28,"alternative-id":["10.1177\/10499091261454918"],"URL":"https:\/\/doi.org\/10.1177\/10499091261454918","relation":{},"ISSN":["1049-9091","1938-2715"],"issn-type":[{"value":"1049-9091","type":"print"},{"value":"1938-2715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"article-number":"10499091261454918"}}